fbpx Medical Cannabis News | Marijuana News | 420intel

Medical Cannabis News

Synonyms: 
mmj
Thu
07
Jul

Why cannabis and yoga are the perfect match

woman's back

With TikTok’s newfound love of pilates, Instagram’s fascination with gut health, and mushroom lattes popping up on the menus of our local coffee shops, it’s clear that “wellness” is going mainstream. But one clear positive exists amongst the health crazes and the diets-in-disguise: more and more people are beginning to understand how our mental and physical wellbeing are intrinsically linked.

Thu
07
Jul

Have you heard about THC-P? We have the scoop!

woman

Did you know that one of the most hyped up cannabinoids to hit the hemp market in recent years has been THC-P (tetrahydrocannabiphorol)?

Trust us when we say the hype around THC-P is thoroughly warranted.  This is potentially the most potent cannabinoid in all of the hemp plant, with a strength thought to be 33 times stronger than regular THC. Yes, 33 times stronger. However, because it’s so new, there is still a lot to learn about it.  

Wed
06
Jul

Death doulas and brain scans herald next stage of LSD research

lab researcher

 

LSD has a Cinderella complex

Amanda Feilding, a British countess and drug-reform advocate, is gaining new influence in the psychedelics industry.

Feilding gained notoriety in the 1970s for an experiment where she drilled a hole in her forehead in search of heightened consciousness. Then, in 1998, she created a nonprofit called the Beckley Foundation, which for years has urged the liberalization of drug laws. Her efforts included addressing the United Nations and publishing a 2011 letter calling for a new approach to the war on drugs, signed by more than 60 world leaders and Nobel Prize winners, including former President Jimmy Carter.

Wed
06
Jul

Anebulo Pharmaceuticals announces positive topline Data for ANEB-001 from a phase 2 clinical trial for Acute Cannabinoid Intoxication

woman eating gummies

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication (ACI) and substance abuse disorders (the “Company” or “Anebulo”), today announced positive topline data from Part A of an ongoing Phase 2 clinical trial evaluating the potential of ANEB-001 to treat ACI. Part A was a 60 subject randomized, double-blind, placebo-controlled trial designed to evaluate the effectiveness of a single dose of ANEB-001 in treating healthy subjects challenged with delta-9-tetrahydrocannabinol, better known as THC, the primary psychoactive constituent of cannabis.

Wed
06
Jul

Using cannabis for anxiety

woman on the floor

 

An excerpt from the Cannabis Health Index

Anxiety is a normal reaction to the subjective experience of stress, such as in “performance anxiety.” It can occur when anticipation of future events is associated in one’s mind with thoughts and feelings not rooted in the present moment. While anxieties can be considered a normal part of life, chronic or constant anxiety can be debilitating to one’s quality of life. In fact, such interference can produce very real physiological changes in the short and long term. It is estimated that almost two out of ten people in the U.S. suffer from anxiety disorder.

Wed
06
Jul

Study shows flower still reigns supreme in U.S., Canada as consumer favorite

woman with cannabis flower

According to data published in the International Journal of Drug Policy, Canadian and U.S. cannabis consumers predominantly consume cannabis flower over other product formulations.

Flower is indeed still king, and new research proves it. The paper, which researchers say is “one of the most comprehensive assessments of cannabis consumption at the population level in Canada and the U.S. to date,” examines trends in cannabis consumption patterns in Canada and the United States between 2018 and 2020, with authors recognizing the “rapidly diversified” market in both countries since the legalization of medical and recreational cannabis.

Tue
05
Jul

Canadian cannabis giant Tilray offers U.S. workers coverage for abortion-related costs

protest

Updated health care benefits will cover transportation expenses for employees and their covered family members.

U.S.-based employees of Tilray Brands will receive coverage should they seek an abortion in the wake of the Supreme Court of the United States overturning five-decades-long protections to access legal abortions.

According to Marijuana Business Daily, the company will cover travel and accommodation expenses, as well as provide paid time off, for those who must travel out of state for the procedure.

‘Health and safety of our employees, patients and consumers is our top priority’

“At Tilray Brands, the health and safety of our employees, patients and consumers is our top priority,” Tilray CEO Irwin Simon noted in a tweet June 28.

Tue
05
Jul

Adolescents more vulnerable to cannabis addiction but not other mental health risks

teenage girl

 

Adolescents are over three times more vulnerable to developing a cannabis addiction than adults, but may not be at increased risk of other mental health problems related to the drug, finds a new study led by UCL and King’s College London researchers.

The study, published today in the Journal of Psychopharmacology, found that adolescents who used cannabis were no more likely to have higher levels of subclinical depression or anxiety than adults who use cannabis, nor were they more vulnerable than adult users to the associations with psychotic-like symptoms.

Tue
05
Jul

Opposition fury at Albanian government plan to legalize medical cannabis

Albanian flag

The Albanian government has put a draft law on legalising medical cannabis up for public consultation, sparking an angry reaction from opposition politicians. 

The news was announced shortly after the latest World Drug Report 2022 from the United Nations Office on Drugs and Crime (UNODC) revealed that Albania is one of the top countries worldwide for cannabis cultivation and distribution. 

Tue
05
Jul

Cannabis use not associated with higher incidence of respiratory-related hospital visits

hospital room

 

Cannabis use does not seem to be associated with more respiratory-related emergency department visits compared non-users of the drug

Cannabis use is not associated with more respiratory-related visits to an emergency department in comparison to those who do not use the drug although it is associated with a greater proportion of overall emergency department visits. This was the main conclusion of a propensity-matched study by a group of researchers from Ontario, Canada.

Pages

Subscribe to RSS - Medical Cannabis News